Dengxiang Liu

机构：Hebei Medical University, China Tobacco, Nanjing University of Posts and Telecommunications, Xingtai People's Hospital · ORCID：0009-0001-7247-223X

发表论文 73 篇 · 总被引 1032 次 · h-index 17

代表论文

• Nanofibrous polycaprolactone/amniotic membrane facilitates peripheral nerve regeneration by promoting macrophage polarization and regulating inflammatory microenvironment (2023 · International Immunopharmacology · 被引 21)
• RETRACTED ARTICLE: Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature (2023 · Functional & Integrative Genomics · 被引 18)
• Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer (2023 · Journal of Translational Medicine · 被引 15)
• Multilayer amnion-PCL nanofibrous membrane loaded with celecoxib exerts a therapeutic effect against tendon adhesion by improving the inflammatory microenvironment (2023 · Heliyon · 被引 12)
• Integrin β4 Regulates Cell Migration of Lung Adenocarcinoma Through FAK Signaling (2024 · Molecular Biotechnology · 被引 5)
• Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study (2023 · Hepatology International · 被引 5)